Norway: Catalysing novel partnerships for global impact
17.10.2025, 19:00 - 21:00 GMT
Seminar
Norway is emerging as a key European driver in Precision Cancer Medicine (PCM), powered by national initiatives and strong partnerships with leading European stakeholders. The Norwegian Government has a strategic plan to make Norway a preferred country for clinical trials, health innovation and industry collaboration. In 2025, Norway and Germany formalised a bilateral Health Partnership.
Join us for a special reception at the Residence of the Norwegian Ambassador in Berlin during ESMO 2025. Meet the Norwegian ESMO Delegation including researchers, clinicians, industry leaders, patient advocates, as well as our distinguished international guests.
You’ll hear directly from experts across the Norwegian health sector on topics such as:
- Norway’s new national clinical trials strategy
- Access to cutting-edge trial units and diagnostics
- How health registries and biobanks enable faster, smarter trials
- Public-private collaboration models that work
- The role of NorTrials as your entry point to all this — and more
The evening opens with a Fireside Chat featuring global oncology thought leaders, followed by a networking dinner in an informal and welcoming setting.
Register your interest by 1 October. Spaces are limited due to venue capacity. Formal invitations will be sent by the Norwegian embassy once the guest list is finalised.
Contact us
For any inquiries regarding the event or registration, please do not hesitate to contact us.
Maria C. Lundstad Aulie
Investment Manager | Greater Oslo region
Health and life science
Signe Øien Fretland
Head of NorTrials coordinating unit; Cand. Pharm.
Jutta Heix
Head of International Affairs, OCC
Martin Nietz
Senior Advisor | D-A-CH
